755092

    0

    AVIENCE

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    AVIENCE BIOMEDICALS LTD Share Price Today

    AVIENCE BIOMEDICALS LTD made its stock market debut on 25 June 2026 and is currently trading at ₹248.45, up by ₹1.94 from the previous close. The stock touched an intraday high of ₹250.00 and a low of ₹240.35 during the latest trading session.

    AVIENCE BIOMEDICALS LTD performance

    Today’s low Today’s high
    ₹ 240.35 ₹ 250.00
    ₹ 248.45
    52 week low 52 week high
    ₹ 222.00 ₹ 414.95
    ₹ 248.45
    Open Price ₹ 241.25
    Prev. Close ₹ 246.50
    Volume (Shares) 22800.00
    Total traded value ₹ 56.64
    Upper Circuit ₹ 295.80
    Lower Circuit ₹ 197.20
    info

    Investment Returns

    Over 1 Month -11.25% Over 3 Months -40.59% Over 6 Months 0.00% Over 1 Year 0.00%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    AVIENCE BIOMEDICALS LTD fundamentals


    • Market cap (Cr) 136.30
    • P/E Ratio (TTM) 20.07
    • Beta -1.59
    • Book Value / share 157.09
    • Return on equity 37.79%
    • EPS (TTM) 12.28
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    AVIENCE BIOMEDICALS LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 35.31
    Operating Expense 26.01
    Net Profit 6.73
    Net Profit Margin (%) 19.05
    Earnings Per Share (EPS) 16.70
    EBITDA 11.08
    Effective Tax Rate (%) 29.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 28.89
    Operating Expense 22.59
    Net Profit 5.00
    Net Profit Margin (%) 17.30
    Earnings Per Share (EPS) 13.19
    EBITDA 8.23
    Effective Tax Rate (%) 27.07
    Particulars MAR 2024 (Values in Cr)
    Revenue 16.26
    Operating Expense 13.89
    Net Profit 2.00
    Net Profit Margin (%) 12.30
    Earnings Per Share (EPS) 6.09
    EBITDA 3.60
    Effective Tax Rate (%) 27.27
    Particulars MAR 2023 (Values in Cr)
    Revenue 10.92
    Operating Expense 9.96
    Net Profit 0.78
    Net Profit Margin (%) 7.14
    Earnings Per Share (EPS) 3.77
    EBITDA 1.44
    Effective Tax Rate (%) 18.75
    Particulars MAR 2022 (Values in Cr)
    Revenue 10.15
    Operating Expense 9.19
    Net Profit 0.71
    Net Profit Margin (%) 6.99
    Earnings Per Share (EPS) 6.86
    EBITDA 1.22
    Effective Tax Rate (%) 26.04
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 56.21
    ROE % 49.17
    ROCE % 33.68
    Total Debt to Total Equity 1.29
    EBITDA Margin 26.75
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 18.96
    ROE % 34.73
    ROCE % 18.41
    Total Debt to Total Equity 2.43
    EBITDA Margin 19.16
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 50.62
    ROE % 37.79
    ROCE % 31.25
    Total Debt to Total Equity 0.81
    EBITDA Margin 28.56
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 18.48
    ROE % 39.49
    ROCE % 31.08
    Total Debt to Total Equity 1.03
    EBITDA Margin 22.32
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 12.41
    ROE % 22.74
    ROCE % 20.45
    Total Debt to Total Equity 0.75
    EBITDA Margin 13.19
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 13.73
    ROE % 25.81
    ROCE % 21.36
    Total Debt to Total Equity 0.89
    EBITDA Margin 12.02
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.93
    Total Assets 56.48
    Total Liabilities 56.48
    Total Equity 22.65
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 12.56
    Return on Capital (%) 15.84
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.35
    Total Assets 34.63
    Total Liabilities 34.63
    Total Equity 6.22
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 6.23
    Return on Capital (%) 10.11
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.75
    Total Assets 43.56
    Total Liabilities 43.56
    Total Equity 20.40
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 11.48
    Return on Capital (%) 14.65
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.20
    Total Assets 25.61
    Total Liabilities 25.61
    Total Equity 6.06
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 7.81
    Return on Capital (%) 14.5
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.39
    Total Assets 10.02
    Total Liabilities 10.02
    Total Equity 4.07
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 7.80
    Return on Capital (%) 11.62
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 6.09
    Total Liabilities 6.09
    Total Equity 2.79
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 11.78
    Return on Capital (%) 13.6
    Particulars MAR 2025 (Values in Cr)
    Net Income 9.76
    Cash from Operations 4.18
    Cash from Investing -9.54
    Cash from Financing 10.20
    Net change in Cash 4.05
    Free Cash Flow 13.48
    Particulars MAR 2024 (Values in Cr)
    Net Income 3.02
    Cash from Operations 1.19
    Cash from Investing -4.02
    Cash from Financing 2.93
    Net change in Cash -0.07
    Free Cash Flow 5.07
    Particulars MAR 2025 (Values in Cr)
    Net Income 6.86
    Cash from Operations 3.79
    Cash from Investing -8.16
    Cash from Financing 9.05
    Net change in Cash 4.03
    Free Cash Flow 11.71
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.74
    Cash from Operations 0.34
    Cash from Investing -4.12
    Cash from Financing 3.80
    Net change in Cash -0.09
    Free Cash Flow 4.32
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.96
    Cash from Operations 1.91
    Cash from Investing -1.93
    Cash from Financing 0.43
    Net change in Cash 0.23
    Free Cash Flow 3.60
    Particulars MAR 2022 (Values in Cr)
    Net Income 0.96
    Cash from Operations -1.80
    Cash from Investing -0.88
    Cash from Financing 2.78
    Net change in Cash -0.06
    Free Cash Flow -0.93
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8921.00 68.63 13.53 128270.29 6680.00 9326.80
    FORTIS MALAR HOSPITALS LIMITED 49.75 0.00 2.71 93.24 40.75 76.00
    SHREE PACETRONIX LTD. 147.60 17.61 3.10 55.35 90.00 283.15
    TRANSGENE BIOTEK LTD. 2.94 0.00 2.65 22.28 1.83 5.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8921.00 91.18 12.87 128270.29 6680.00 9326.80
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 39.85 0.00 -9.69 29.77 30.30 57.48
    KOVAI MEDICAL CENTER & HOSPITA 6159.95 26.29 5.10 6738.99 5010.00 6725.00

    AVIENCE BIOMEDICALS LTD shareholding pattern

    Holding
    23.26%
    64.59%
    3.06%
    9.08%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    AVIENCE BIOMEDICALS LTD Technicals Summary

    248.45 0.79 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 249.20
    • 26 Days 275.30
    • 10 Days 252.60
    • 50 Days 282.50
    • 12 Days 254.60
    • 100 Days 282.50
    • 20 Days 266.80
    • 200 Days 282.50
    249.52 PIVOT
    First Support 243.48 First Resistance 252.53 Second Support 240.47 Second Resistance 258.57 Third Support 234.43 Third Resistance 261.58
    RSI 28.22 ADX 51.44 MACD -20.67 Williams % R -72.54 Commodity Channel Index (CCI) -56.93
    Date 2026-08-10 Week 11400.00 Same Day 6600.00 Month 46255.00
    1 Year -1.59 3 Year -1.52
    Over 1 Month
    -11.25% down
    Over 1 Year
    0.00% down
    Over 3 Months
    -40.59% down
    Over 3 Years
    0.00% down
    Over 6 Months
    0.00% down
    Over 5 Years
    0.00% down

    AVIENCE BIOMEDICALS LTD Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Avience Biomedicals Ltd?

    Answer Field

    Avience Biomedicals Ltd share price is for NSE ₹ 248.45 & for BSE ₹ 0.00 as on Aug 11 2026 01:03 PM.

    What is the Market Cap of Avience Biomedicals Ltd Share?

    Answer Field

    The market cap of Avience Biomedicals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 11 2026 01:03 PM.

    What is the 52 Week High and Low of Avience Biomedicals Ltd?

    Answer Field

    The 52 Week High and Low of Avience Biomedicals Ltd for NSE is ₹ 414.95 and ₹ 222.00 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Avience Biomedicals Ltd?

    Answer Field

    The 1 year returns on the stock has been 0.00%.

    What is the P/E Ratio of Avience Biomedicals Ltd Share?

    Answer Field

    As on Aug 11 2026 01:03 PM the price-to-earnings (PE) ratio for Avience Biomedicals Ltd share is 20.07.

    What is the PB ratio of Avience Biomedicals Ltd Share?

    Answer Field

    As on Aug 11 2026 01:03 PM, the price-to-book (PB) ratio for Avience Biomedicals Ltd share is 157.09.

    How to Buy Avience Biomedicals Ltd Share?

    Answer Field

    You can trade in Avience Biomedicals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Avience Biomedicals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Avience Biomedicals Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Avience Biomedicals Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |